Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aliki Xochelli

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
British Journal of Haematology|March 7, 2022
International validation of the EORTC QLQ-CLL17 questionnaire for assessment of health-related quality of life for patients with chronic lymphocytic leukaemiaSimone Oerlemans, Fabio Efficace, Jacobien M Kieffer, et al.
Blood Advances|September 22, 2023
International validation of a health-related quality-of-life questionnaire for Hodgkin lymphoma: the EORTC QLQ-HL27Simone Oerlemans, Fabio Efficace, Omar Shamieh, et al.
Haematologica|April 23, 2016
Additional trisomies amongst patients with chronic lymphocytic leukemia carrying trisomy 12: the accompanying chromosome makes a differencePanagiotis Baliakas, Anna Puiggros, Aliki Xochelli, et al.
Immunogenetics|November 13, 2014
Immunoglobulin heavy variable (IGHV) genes and alleles: new entities, new names and implications for research and prognostication in chronic lymphocytic leukaemiaAliki Xochelli, Andreas Agathangelidis, Ioannis Kavakiotis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2015
Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep SequencingMarina Parry, Matthew Jj Rose-Zerilli, Viktor Ljungström, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2015
An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 ReceptorsVasilis Bikos, Maria Karypidou, Evangelia Stalika, et al.
Oncotarget|November 9, 2016
Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrationsGonzalo Blanco, Anna Puiggros, Panagiotis Baliakas, et al.
Blood|January 11, 2017
Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutationsSoraya Curiel-Olmo, Rufino Mondéjar, Carmen Almaraz, et al.
Cancer|May 19, 2023
International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20)Simone Oerlemans, Fabio Efficace, Charalampia Kyriakou, et al.
Haematologica|September 29, 2018
Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemiaPanagiotis Baliakas, Theodoros Moysiadis, Anastasia Hadzidimitriou, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
British Journal of Haematology|March 7, 2022
International validation of the EORTC QLQ-CLL17 questionnaire for assessment of health-related quality of life for patients with chronic lymphocytic leukaemiaSimone Oerlemans, Fabio Efficace, Jacobien M Kieffer, et al.
Blood Advances|September 22, 2023
International validation of a health-related quality-of-life questionnaire for Hodgkin lymphoma: the EORTC QLQ-HL27Simone Oerlemans, Fabio Efficace, Omar Shamieh, et al.
Haematologica|April 23, 2016
Additional trisomies amongst patients with chronic lymphocytic leukemia carrying trisomy 12: the accompanying chromosome makes a differencePanagiotis Baliakas, Anna Puiggros, Aliki Xochelli, et al.
Immunogenetics|November 13, 2014
Immunoglobulin heavy variable (IGHV) genes and alleles: new entities, new names and implications for research and prognostication in chronic lymphocytic leukaemiaAliki Xochelli, Andreas Agathangelidis, Ioannis Kavakiotis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2015
Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep SequencingMarina Parry, Matthew Jj Rose-Zerilli, Viktor Ljungström, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2015
An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 ReceptorsVasilis Bikos, Maria Karypidou, Evangelia Stalika, et al.
Oncotarget|November 9, 2016
Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrationsGonzalo Blanco, Anna Puiggros, Panagiotis Baliakas, et al.
Blood|January 11, 2017
Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutationsSoraya Curiel-Olmo, Rufino Mondéjar, Carmen Almaraz, et al.
Cancer|May 19, 2023
International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20)Simone Oerlemans, Fabio Efficace, Charalampia Kyriakou, et al.
Haematologica|September 29, 2018
Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemiaPanagiotis Baliakas, Theodoros Moysiadis, Anastasia Hadzidimitriou, et al.
Pageof 6